SCHEMBL20009240

SCHEMBL20009240

CCOc1ccc(C(=O)OC(CS(=O)(=O)O)C(F)(F)F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.44
NPSR1 Q6W5P4 2/20 0.44
HPGD P15428 1/20 0.44
GAA P10253 1/20 0.43
NPC1 O15118 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
RAB9A P51151 1/20 0.43
PLK1 P53350 1/20 0.42
ALDH1A1 P00352 2/20 0.42
LMNA P02545 1/20 0.42
SCN1A P35498 1/20 0.42
SCN2A Q99250 1/20 0.42
SCN3A Q9NY46 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 1/20 0.41
CYP1A1 P04798 1/20 0.41
CYP1B1 Q16678 1/20 0.41
MAOB P27338 1/20 0.41
PLA2G4B P0C869 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18775779 0.88 CA1 (0.45) NPSR1GAANPC1L3MBTL1RAB9A
SCHEMBL18775680 0.86 POLB (0.42) HPGDNPC1RAB9APLK1ALDH1A1
SCHEMBL18775911 0.86 SMN1; SMN2 (0.38) HPGDALDH1A1LMNAKMT2AMEN1
SCHEMBL18775684 0.86 MAPT (0.41) NPC1L3MBTL1RAB9ALMNAMAPT
SCHEMBL18775773 0.85 TDP1 (0.41) NPSR1GAANPC1L3MBTL1RAB9A
SCHEMBL18775747 0.83 CA12 (0.46) NPC1RAB9AALDH1A1LMNAMAPT
SCHEMBL18775869 0.83 KMT2A (0.40) NPC1RAB9AMAPTKMT2AMEN1
SCHEMBL27273377 0.83 MAPT (0.38) GAAL3MBTL1RAB9AALDH1A1LMNA
SCHEMBL18891086 0.83 ELANE (0.36) NPSR1HPGDGAAL3MBTL1ALDH1A1
SCHEMBL18775687 0.83 CYP4A11 (0.43) GAANPC1L3MBTL1RAB9APLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10808148-B2 Adhesive composition, bio-electrode, method for manufacturing a bio-electrode, and salt SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-10-20 US disclosed
US-20180086948-A1 ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-03-29 US disclosed
US-20180086948-A1 ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10808148-B2 Adhesive composition, bio-electrode, method for manufacturing a bio-electrode, and salt SLC9A1, FN1, EPCAM PARP10 1161/4885NPSR1 1435/4885HPGD 3512/4885
US-20180086948-A1 ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT SLC9A1, FN1, EPCAM PARP10 1165/4885NPSR1 1435/4885HPGD 3498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.